1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVO NORDISK - ADR
Novo Nordisk - ADR XNYS: NVO
Await Turnaround
Download real time
47.86 -0.13 (-0.27%)
57.46% Fall from 52W High
15.3M
XNYS Volume

XNYS 05 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Acquisition Approval
Novo Nordisk gets approval by German antitrust authorities to acquire Akero Therapeutics See details

Novo Nordisk (ADR) - NVO - stock price prediction, stock price target, analyst ratings from 12 analysts

Novo Nordisk (ADR) has a share price target of US$ 53, revenue growth forecast of 18.9%, and profit growth estimate of 14.2% for FY25, based on top 12 analyst calls.

Forecaster Screeners